Ligand-independent Androgen Receptor Activity Is Activation Function-2-independent and Resistant to Antiandrogens in Androgen Refractory Prostate Cancer Cells

Scott M. Dehm(University of Minnesota), Donald J. Tindall

Journal of Biological Chemistry

July 27, 2006

10.1074/jbc.m605002200

Cited by 113

Related Papers

Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies

|Nucleic Acids Research|2015|151

Evolution of <i>AR</i> and Non- <i>AR</i> Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial

|Clinical Cancer Research|2026|1

Supplementary Materials and Methods from Targeting a Single Alternative Polyadenylation Site Coordinately Blocks Expression of Androgen Receptor mRNA Splice Variants in Prostate Cancer

|Unknown|2023|0

Supplementary Materials and Methods from Targeting a Single Alternative Polyadenylation Site Coordinately Blocks Expression of Androgen Receptor mRNA Splice Variants in Prostate Cancer

|Unknown|2023|0